Olivia H. Wright, NP-C
Nurse Practitioners (Family Nurse Practitioner)
- Medicare participating
At a glance
- Years since graduation
- 12
- In the NPI registry since
- 2015
- Medicare patients seen, 2024
- 38
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Nurse Practitioner primary
AL license 3-000805
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Dch Regional Medical Center Tuscaloosa, AL
Medical groups
- West Alabama Family Practice and Sports Medicine PC (7 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 38
- Services billed
- 54
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, ceftriaxone sodium, per 250 mg | 132 | 33 |
| Injection, dexamethasone sodium phosphate, 1 mg | 88 | 22 |
| Injection of drug or substance under skin or into muscle | 67 | 44 |
| Established patient office or other outpatient visit, 30-39 minutes | 46 | 43 |
| Detection test by immunoassay with direct visual observation for influenza virus | 43 | 21 |
| Established patient office or other outpatient visit, 20-29 minutes | 39 | 36 |
| Urinalysis, manual test | 21 | 20 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 14 | 14 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 13 | 12 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 82 payments worth $1,431 in total to this clinician.
| Amgen Inc. | $204 |
|---|---|
| Lilly USA, LLC | $188 |
| Pfizer Inc. | $185 |
| Corium, LLC | $153 |
| Bard Peripheral Vascular, Inc. | $146 |
| Bayer HealthCare Pharmaceuticals Inc. | $110 |
| AstraZeneca Pharmaceuticals LP | $86.91 |
| Dexcom, Inc. | $53.54 |
| Food and Beverage | $1,431 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.